The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR) (R43/R44 Clinical Trial Not Allowed)
The purpose of this Funding Opportunity Announcement (FOA) is to encourage New or Renewal Small Business Innovation Research (SBIR) grant applications focused on specific product development activities for radiological/nuclear medical countermeasures leading to Investigational New Drug (IND) or Investigational Device Exemption (IDE) submission packages to the U.S. Food and Drug Administration.
Deadlines: Sep. 5, Jan. 5, Apr. 5
PA-18-525 Expiration Date January 6, 2021
Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.
Budgets up to $300,000 total costs per year for Phase I and up to $1,000,000 total costs per year for Phase II may be requested.